Mark A. Villamil

861 total citations
10 papers, 669 citations indexed

About

Mark A. Villamil is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Mark A. Villamil has authored 10 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Mark A. Villamil's work include Ubiquitin and proteasome pathways (8 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Cancer-related Molecular Pathways (4 papers). Mark A. Villamil is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Cancer-related Molecular Pathways (4 papers). Mark A. Villamil collaborates with scholars based in United States, China and Hungary. Mark A. Villamil's co-authors include Zhihao Zhuang, Liang Qin, Junjun Chen, Thomas S. Dexheimer, Anton Simeonov, David J. Maloney, Ajit Jadhav, Yongxing Ai, Andrew S. Rosenthal and James Inglese and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Mark A. Villamil

10 papers receiving 653 citations

Peers

Countries citing papers authored by Mark A. Villamil

Since Specialization

Citations

This map shows the geographic impact of Mark A. Villamil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Villamil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Villamil more than expected).

Fields of papers citing papers by Mark A. Villamil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Villamil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Villamil. The network helps show where Mark A. Villamil may publish in the future.

Co-authorship network of co-authors of Mark A. Villamil

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Villamil. A scholar is included among the top collaborators of Mark A. Villamil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Villamil. Mark A. Villamil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Interaction of histone H4 with Cse4 facilitates conformational changes in Cse4 for its sumoylation and mislocalization 2023 ·Nucleic Acids Research ·Kentaro Ohkuni, Wei-Chun Au, (unknown), Mark A. Villamil, Peter Kaiser, Munira A. Basrai	2
2	The Ubiquitin Interacting Motif-Like Domain of Met4 Selectively Binds K48 Polyubiquitin Chains 2021 ·Molecular & Cellular Proteomics ·Mark A. Villamil, Weidi Xiao, Clinton Yu, Lan Huang, Ping Xu, Peter Kaiser	4
3	Synthesis and Structure–Activity Relationship Studies ofN-Benzyl-2-phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer 2014 ·Journal of Medicinal Chemistry ·Thomas S. Dexheimer, Andrew S. Rosenthal, Diane K. Luci, Liang Qin, Mark A. Villamil, Junjun Chen, Hongmao Sun, Edward H. Kerns, Anton Simeonov, Ajit Jadhav, Zhihao Zhuang, David J. Maloney	52
4	Discovery of ML323 as a Novel Inhibitor of the USP1/UAF1 Deubiquitinase Complex 2014 ·Europe PMC (PubMed Central) ·Thomas S. Dexheimer, Andrew S. Rosenthal, Liang Qin, Junjun Chen, Mark A. Villamil, Edward H. Kerns, Anton Simeonov, Ajit Jadhav, Zhihao Zhuang, David J. Maloney	25
5	A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses 2014 ·Nature Chemical Biology ·Liang Qin, Thomas S. Dexheimer, (unknown), Andrew S. Rosenthal, Mark A. Villamil, Changjun You, Qiuting Zhang, Junjun Chen, (unknown), Hongmao Sun, Diane K. Luci, Bi‐Feng Yuan, Anton Simeonov, Ajit Jadhav, Hui Xiao, Yinsheng Wang, David J. Maloney, Zhihao Zhuang	202
6	The WD40-Repeat Protein-Containing Deubiquitinase Complex: Catalysis, Regulation, and Potential for Therapeutic Intervention 2013 ·Cell Biochemistry and Biophysics ·Mark A. Villamil, Liang Qin, Zhihao Zhuang	37
7	Characterization of human Spartan/C1orf124, an ubiquitin-PCNA interacting regulator of DNA damage tolerance 2012 ·Nucleic Acids Research ·Szilvia Juhász, D. Balogh, Ildikó Hajdú, Peter Burkovics, Mark A. Villamil, Zhihao Zhuang, Lajos Haracska	82
8	Serine Phosphorylation Is Critical for the Activation of Ubiquitin-Specific Protease 1 and Its Interaction with WD40-Repeat Protein UAF1 2012 ·Biochemistry ·Mark A. Villamil, Liang Qin, Junjun Chen, Yong Seok Choi, Shuyu Hou, Kelvin H. Lee, Zhihao Zhuang	40
9	A Noncanonical Cysteine Protease USP1 Is Activated through Active Site Modulation by USP1-Associated Factor 1 2012 ·Biochemistry ·Mark A. Villamil, Junjun Chen, Liang Qin, Zhihao Zhuang	44
10	Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells 2011 ·Chemistry & Biology ·Junjun Chen, Thomas S. Dexheimer, Yongxing Ai, Liang Qin, Mark A. Villamil, James Inglese, David J. Maloney, Ajit Jadhav, Anton Simeonov, Zhihao Zhuang	181

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact